Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis. [PDF]
Adam de Beaumais T +7 more
europepmc +1 more source
Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6-Mercaptopurine Treatment. [PDF]
Khaeso K +8 more
europepmc +1 more source
Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia. [PDF]
Ali AM +5 more
europepmc +1 more source
6-mercaptopurine and tofacitinib alter microbial protein expression but not composition in fecal microbiota incubations from Crohn's disease patients. [PDF]
Becker HEF +5 more
europepmc +1 more source
Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential. [PDF]
Singh B +4 more
europepmc +1 more source
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. [PDF]
Hasskamp J +3 more
europepmc +1 more source
Gold nanoparticles loaded chitosan encapsulate 6-mercaptopurine as a novel nanocomposite for chemo-photothermal therapy on breast cancer. [PDF]
Faid AH +5 more
europepmc +1 more source
Characteristics of 6-Mercaptopurine-Resistant L1210 Cells Newly Developed by in vivo and in vitro Treatment with 6-Mercaptopurine [PDF]
6-Mercaptopurine-resistant sublines of L1210 cell were obtained by in vivo and in vitro treatment with 6-mercaptopurine. These 27 sublines were classified into high- and low-resistant sublines.
Mitsuhashi, Susumu +5 more
core
371-3796-Mercaptopurine (6-MP) is a critical medication used in the remission-maintenance phase of pediatric acute lymphoblastic leukemia (ALL). Mercaptopurine has a narrow therapeutic index with treatment-related toxicities and resistance as major ...
Manda, Sasidhar V +4 more
core +1 more source
Investigating adsorption of 5-fluorouracil and 6-mercaptopurine on icosahedral silver nanoparticles through DFT and TDDFT. [PDF]
Morad R.
europepmc +1 more source

